Range Financial Group LLC Makes New $649,000 Investment in Bausch Health Companies Inc. (NYSE:BHC)

Range Financial Group LLC bought a new position in Bausch Health Companies Inc. (NYSE:BHCFree Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 80,901 shares of the company’s stock, valued at approximately $649,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Nomura Holdings Inc. grew its stake in shares of Bausch Health Companies by 67.7% during the 3rd quarter. Nomura Holdings Inc. now owns 18,086,000 shares of the company’s stock worth $148,667,000 after purchasing an additional 7,303,015 shares during the period. Mizuho Markets Americas LLC purchased a new position in shares of Bausch Health Companies in the 3rd quarter valued at about $57,540,000. Goldentree Asset Management LP raised its holdings in Bausch Health Companies by 19.6% in the 3rd quarter. Goldentree Asset Management LP now owns 23,987,462 shares of the company’s stock worth $197,177,000 after purchasing an additional 3,931,234 shares during the period. Norges Bank purchased a new position in Bausch Health Companies during the fourth quarter worth approximately $20,553,000. Finally, Hudson Bay Capital Management LP grew its holdings in Bausch Health Companies by 35.3% in the third quarter. Hudson Bay Capital Management LP now owns 11,500,000 shares of the company’s stock valued at $94,530,000 after purchasing an additional 3,000,000 shares during the period. 74.56% of the stock is owned by institutional investors and hedge funds.

Bausch Health Companies Stock Up 1.3 %

Shares of NYSE BHC opened at $9.32 on Monday. The company has a market capitalization of $3.41 billion, a P/E ratio of -5.68 and a beta of 0.83. Bausch Health Companies Inc. has a 1 year low of $5.57 and a 1 year high of $10.15. The company has a debt-to-equity ratio of 74.20, a current ratio of 1.30 and a quick ratio of 0.94. The company has a 50 day simple moving average of $8.62 and a 200-day simple moving average of $7.94.

Bausch Health Companies (NYSE:BHCGet Free Report) last released its quarterly earnings results on Thursday, February 22nd. The company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.14. Bausch Health Companies had a positive return on equity of 5,147.48% and a negative net margin of 6.76%. The company had revenue of $2.41 billion for the quarter, compared to analysts’ expectations of $2.29 billion. During the same period in the prior year, the firm earned $1.02 earnings per share. The firm’s revenue was up 9.8% compared to the same quarter last year. On average, equities research analysts predict that Bausch Health Companies Inc. will post 3.92 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on BHC shares. Jefferies Financial Group dropped their price target on shares of Bausch Health Companies from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, February 20th. Royal Bank of Canada increased their price objective on Bausch Health Companies from $8.00 to $9.00 and gave the company a “sector perform” rating in a research note on Friday, February 23rd. Finally, StockNews.com raised shares of Bausch Health Companies from a “hold” rating to a “buy” rating in a research note on Wednesday, February 7th.

Read Our Latest Research Report on BHC

Bausch Health Companies Profile

(Free Report)

Bausch Health Companies Inc operates as a diversified pharmaceutical company. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.

Further Reading

Want to see what other hedge funds are holding BHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bausch Health Companies Inc. (NYSE:BHCFree Report).

Institutional Ownership by Quarter for Bausch Health Companies (NYSE:BHC)

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.